SUP-T1

95013123, human blood, Lymphoblast

• UNSPSC Code: 41106514
• biological source: human blood
• growth mode: Suspension
• karyotype: 92XXXY, -2, -2, -9, -9, 2inv(2*)(p21q11), +2inv(2), del(2*)(Q21), 2del(4)(q31q35), 2del (5)(p13p14), 2del(6)(q23q27), inv(14)(q11q32), t(7;9)(q34,q34), +der(9)t(7;9). Undergone Tetraploidisation
• morphology: Lymphoblast
• products: Not specified
• receptors: CD4
• relevant disease(s): cancer

Propiedades

• Nombre del producto: SUP-T1, 95013123
• biological source: human blood
• growth mode: Suspension
• karyotype: 92XXXY, -2, -2, -9, -9, 2inv(2*)(p21q11), +2inv(2), del(2*)(Q21), 2del(4)(q31q35), 2del (5)(p13p14), 2del(6)(q23q27), inv(14)(q11q32), t(7;9)(q34,q34), +der(9)t(7;9). Undergone Tetraploidisation
• morphology: Lymphoblast
• products: Not specified
• receptors: CD4
• technique(s): cell culture | mammalian: suitable
• relevant disease(s): cancer
• shipped in: dry ice
• storage temp.: −196°C

Descripción

Cell Line Origin

Human T cell lymphoblastic Lymphoma

Cell Line Description

Derived from a Malignant pleural effusion taken from an eight year old caucasian male with T cell lymphoblastic lymphoma. These cells are E-rosette, Leu 5, OKT9 and CALLA negative. They also express β2M, Leu 1, 2, 3a, 4, 6, 9 and OKT10 antigens and are CD4 positive. These cells are negative for Tac, HLA-DR and surface immunoglobulin.

Application

Cells have been used for growth of HIV-1

SUP-T1 has been used in a study targeting B-cell neoplasia with T-cell receptors recognizing a cluster of differentiation 20 (CD20)-derived peptide on patient-specific human leucocyte antigen (HLA). Existing appl-SUP-T1 cells have been used for growth of HIV-1.

Culture Medium

RPMI 1640 + 2mM Glutamine + 10% Foetal Bovine Serum (FBS).

Subculture Routine

Maintain cultures between 2x100,000 to 2x1,000,000 cells/ml 5% CO₂; 37°C.

Other Notes

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.